Finally, the overall analysis of NGS data from BC tissues revealed additional mutations, mainly in ERBB2 and PIK3CA and occurring in 6/8 BC cases, which were not otherwise demonstrable in the matched CTCs as the genomic mutated positions did not overlap with those covered by the OBcfRAv2 panel. The gene discussed is ERBB2; the disease is breast cancer.